Prognosis of Pineal Region Tumors in Children: A Population-Based Study

Fengqiang Shen1, Nan Shen2, Chen Wang3

  • 1Department of Pediatrics, The First Affiliated Hospital of Huzhou Normal University, the First People's Hospital of Huzhou, Huzhou, China.

World Neurosurgery
|November 22, 2024
PubMed

Insights

Pediatric pineal region tumors (PRTs) survival is impacted by age and tumor type. Younger children and those with pineoblastomas face worse outcomes, while radiation therapy improves survival rates for PRTs.

Area of Science:

  • Pediatric Oncology
  • Neuro-oncology
  • Cancer Epidemiology

Background:

  • Pineal region tumors (PRTs) are rare in children, necessitating research into their prognostic factors and survival.
  • Understanding survival outcomes is crucial for developing effective treatment strategies for pediatric PRTs.

Purpose of the Study:

  • To evaluate prognostic factors influencing survival in pediatric patients diagnosed with malignant pineal region tumors.
  • To analyze survival outcomes using a large population-based registry.

Main Methods:

  • Retrospective cohort study using Surveillance, Epidemiology, and End Results (SEER) data (2000-2019).
  • Inclusion of pediatric patients (0-18 years) with histologically verified malignant PRTs.
  • Survival analyses performed using Kaplan-Meier and Cox proportional hazards models; a predictive nomogram was developed.

Main Results:

  • A cohort of 596 pediatric patients with PRTs was analyzed.
  • Germ cell tumors (63.3%) were most common, followed by pineoblastomas (26.3%); overall 5-year survival was 79.6%.
  • Significant predictors of survival included age at diagnosis, SEER stage, histology, and radiation therapy; younger age and pineoblastomas correlated with poorer outcomes.

Conclusions:

  • Early age at diagnosis and aggressive histologies like pineoblastomas are linked to worse survival in pediatric PRTs.
  • Radiation therapy demonstrates a positive association with improved survival.
  • Future research should integrate histological and molecular profiles to refine therapeutic protocols for pediatric PRTs.
Abstract